Clinical Trial: Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07563881) titled 'Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures' on April 16.

Brief Summary: This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Focal Seizure Epilepsy Focal Epilepsy

Intervention: DRUG: RAP-219

RAP-219 high dose tablets administered orally daily

DRUG: RAP-219

RAP-219 medium dose tablets administered orally daily

OTHER: Placebo

Matching...